Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Berkman

Showing results (191-200 of 210) with videos related to

Pageof 21
Sort By:
Bioconjugate Chemistry|October 26, 2021
Prostate-Specific Membrane Antigen-Targeted Turn-on Probe for Imaging Cargo Release in Prostate Cancer CellsFeyisola P Olatunji, Emily A Savoy, Mylan Panteah, et al.
Bioorganic & Medicinal Chemistry|October 23, 2004
Stereoselective inhibition of glutamate carboxypeptidase by organophosphorus derivatives of glutamic acidJeremy P Mallari, Cindy J Choy, Ying Hu, et al.
The American Journal of Bioethics : AJOB|September 13, 2013
What does the duty to warn require?Seema K Shah, Sara Chandros Hull, Michael A Spinner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 14, 2009
Assessment of an 18F-labeled phosphoramidate peptidomimetic as a new prostate-specific membrane antigen-targeted imaging agent for prostate cancerSuzanne E Lapi, Hilla Wahnishe, David Pham, et al.
Blood|September 25, 2001
Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantationU Narayanasami, R Kanteti, J Morelli, et al.
The Prostate|January 23, 2014
Biochemical characterization of prostate-specific membrane antigen from canine prostate carcinoma cellsLisa Y Wu, Jacqueline M Johnson, Jessica K Simmons, et al.
Biomacromolecules|August 21, 2024
PSMA-Targeted 2-Deoxyglucose-Based Dendrimer Nanomedicine for the Treatment of Prostate CancerAnu Rani, Anunay James Pulukuri, Jing Wei, et al.
Molecular Cancer Therapeutics|August 24, 2022
Modular Smart Molecules for PSMA-Targeted ChemotherapyFeyisola P Olatunji, Michael Pun, Jacob W Herman, et al.
Nuclear Medicine and Biology|July 15, 2015
A high-affinity [(18)F]-labeled phosphoramidate peptidomimetic PSMA-targeted inhibitor for PET imaging of prostate cancerTanushree Ganguly, Shorouk Dannoon, Mark R Hopkins, et al.
Journal of Chemical Information and Modeling|January 15, 2024
Structural, Biochemical, and Computational Characterization of Sulfamides as Bimetallic Peptidase InhibitorsZora Novakova, Zahra Aliakbar Tehrani, Radek Jurok, et al.
Pageof 21

Showing results (191-200 of 210) with videos related to

Sort By:
Pageof 21
Bioconjugate Chemistry|October 26, 2021
Prostate-Specific Membrane Antigen-Targeted Turn-on Probe for Imaging Cargo Release in Prostate Cancer CellsFeyisola P Olatunji, Emily A Savoy, Mylan Panteah, et al.
Bioorganic & Medicinal Chemistry|October 23, 2004
Stereoselective inhibition of glutamate carboxypeptidase by organophosphorus derivatives of glutamic acidJeremy P Mallari, Cindy J Choy, Ying Hu, et al.
The American Journal of Bioethics : AJOB|September 13, 2013
What does the duty to warn require?Seema K Shah, Sara Chandros Hull, Michael A Spinner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 14, 2009
Assessment of an 18F-labeled phosphoramidate peptidomimetic as a new prostate-specific membrane antigen-targeted imaging agent for prostate cancerSuzanne E Lapi, Hilla Wahnishe, David Pham, et al.
Blood|September 25, 2001
Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantationU Narayanasami, R Kanteti, J Morelli, et al.
The Prostate|January 23, 2014
Biochemical characterization of prostate-specific membrane antigen from canine prostate carcinoma cellsLisa Y Wu, Jacqueline M Johnson, Jessica K Simmons, et al.
Biomacromolecules|August 21, 2024
PSMA-Targeted 2-Deoxyglucose-Based Dendrimer Nanomedicine for the Treatment of Prostate CancerAnu Rani, Anunay James Pulukuri, Jing Wei, et al.
Molecular Cancer Therapeutics|August 24, 2022
Modular Smart Molecules for PSMA-Targeted ChemotherapyFeyisola P Olatunji, Michael Pun, Jacob W Herman, et al.
Nuclear Medicine and Biology|July 15, 2015
A high-affinity [(18)F]-labeled phosphoramidate peptidomimetic PSMA-targeted inhibitor for PET imaging of prostate cancerTanushree Ganguly, Shorouk Dannoon, Mark R Hopkins, et al.
Journal of Chemical Information and Modeling|January 15, 2024
Structural, Biochemical, and Computational Characterization of Sulfamides as Bimetallic Peptidase InhibitorsZora Novakova, Zahra Aliakbar Tehrani, Radek Jurok, et al.
Pageof 21